| P2093 | author name string | Feng Shen | |
| | Chao Sun | |
| | Jian-Gao Fan | |
| | Shi-Yan Yan | |
| | Xiao-Lin Liu | |
| | Qin Pan | |
| | Zheng-Jie Xu | |
| | Yuan-Wen Chen | |
| | Rui-Nan Zhang | |
| P2860 | cites work | miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis | Q28235822 |
| | Epidemiology of non-alcoholic fatty liver disease in China. | Q30373353 |
| | MicroRNA-192 suppresses liver metastasis of colon cancer | Q33594662 |
| | MicroRNAs in liver disease | Q33880442 |
| | Circulating microRNAs in patients with non-alcoholic fatty liver disease | Q34179239 |
| | Risk stratification of HBV infection in Asia-Pacific region. | Q34339577 |
| | EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Q34676840 |
| | Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis | Q34778143 |
| | Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet | Q34796362 |
| | MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury. | Q35750622 |
| | Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis. | Q35840874 |
| | Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease | Q35993416 |
| | Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease | Q36018329 |
| | Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho | Q36342875 |
| | Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation | Q36591967 |
| | Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients | Q36602293 |
| | Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States | Q36756206 |
| | The global burden of liver disease: the major impact of China | Q36901892 |
| | Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis | Q37581357 |
| | Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases | Q38018832 |
| | Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. | Q38062786 |
| | Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7. | Q38864495 |
| | The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease | Q40294716 |
| | Epidemiology and Clinical Evolution of Liver Cirrhosis in Singapore. | Q40622677 |
| | Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States | Q41626076 |
| | Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma | Q42176710 |
| | MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1 | Q42591732 |
| | Retinoid X receptor α in human liver is regulated by miR-34a. | Q42660683 |
| | A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. | Q44527614 |
| | Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease. | Q44583057 |
| | Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Q44920531 |
| | Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. | Q46124754 |
| | Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122. | Q50942777 |
| | Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. | Q51353878 |
| | Expression levels of microRNA-192 and -215 in gastric carcinoma. | Q54332043 |
| | miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease | Q60895711 |
| | Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease | Q87340617 |
| | Hepatitis B virus infection | Q88131866 |
| P433 | issue | 44 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatohepatitis | Q2335423 |
| | non-alcoholic steatohepatitis | Q28692677 |
| | diagnostic marker | Q129938486 |
| P304 | page(s) | 9844-9852 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population | |
| P478 | volume | 22 | |